ACT-AEC First Annual Meeting

To enhance the impact of trial networks in Canada, ACT is holding a call for networks to join the ACT-2 grant application. Within the proposal,

The Accelerating Clinical Trials (ACT) Consortium recently held a competition for ACT Network members to support innovative knowledge mobilization practices. Knowledge mobilization is a key

The Accelerating Clinical Trials (ACT) Consortium recently held a competition to bring high-impact randomized controlled trials to Canada that were initiated and are led by

International review panel selects CanReview to set up, initiate, and conduct a pan-Canadian single REB review and approval process with strict timelines. The Accelerating Clinical

Click here for a full summary of the ACT October Meeting In preparation for the Third ACT Consortium Meeting, we are seeking Canadian biotechnology companies